Latest News in the Life Sciences Industry
PR Newswire Association LLC.
Perceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with Trialzen
27 Apr 2026
PR Newswire Association LLC.
Global Food & Beverage Disinfection & Cleaning Market Outlook 2025-2035 | North America & Europe Expansion Driven by 3M Company, BASF SE
27 Apr 2026
PR Newswire Association LLC.
Simple glove change could save the NHS £45 million over five years and improve caesarean safety
27 Apr 2026
GlobeNewswire
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU
27 Apr 2026
PR Newswire Association LLC.
Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
24 Apr 2026
GlobeNewswire
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)
24 Apr 2026
PR Newswire Association LLC.
Amcor opens advanced healthcare packaging coating facility in Malaysia
24 Apr 2026
GlobeNewswire
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
24 Apr 2026
GlobeNewswire
Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes
23 Apr 2026
GlobeNewswire
New funding opportunities pave the way for better diagnostics and treatment as well as for engineering efficient biosolutions and replacing critical and scarce resources
23 Apr 2026
GlobeNewswire
Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026
23 Apr 2026
GlobeNewswire
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
23 Apr 2026
GlobeNewswire
Picard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026
22 Apr 2026
GlobeNewswire
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
22 Apr 2026
GlobeNewswire
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
21 Apr 2026
PR Newswire Association LLC.
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026
21 Apr 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan